| |
| |
|
| Insider
Information: |
Iannone Robert |
| Relationship: |
EVP, Global Head of R&D |
| City: |
Morris Plains |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
62,226 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,799,435 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
62,226 |
|
|
| Total
Value |
$6,799,435 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunomedics Inc |
IMMU |
|
|
0 |
|
0 |
Premium* |
|
|
Jazz Pharmaceuticals Inc |
JAZZ |
EVP, Global Head of R&D |
2024-03-05 |
62,226 |
2019-08-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Global Head of R&D |
• – – |
2024-03-05 |
4 |
D |
$117.53 |
$504,674 |
D/D |
(4,294) |
62,226 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Global Head of R&D |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
16,928 |
66,520 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Global Head of R&D |
• – – |
2024-01-17 |
4 |
D |
$119.13 |
$206,095 |
D/D |
(1,730) |
49,592 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Global Head of R&D |
• – – |
2024-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
5,970 |
51,322 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Global Head of Research a |
• – – |
2023-06-05 |
4 |
D |
$129.73 |
$170,076 |
D/D |
(1,311) |
45,315 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Global Head of Research a |
• – – |
2023-03-05 |
4 |
D |
$142.78 |
$324,682 |
D/D |
(2,274) |
46,489 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Global Head of Research a |
• – – |
2023-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
12,447 |
48,763 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Global Head of R&D |
• – – |
2022-12-09 |
4 |
S |
$151.54 |
$279,440 |
D/D |
(1,844) |
36,316 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Global Head of R&D |
• – – |
2022-06-06 |
4 |
D |
$149.25 |
$193,279 |
D/D |
(1,295) |
38,109 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Global Head of R&D and Ch |
• – – |
2022-03-05 |
4 |
D |
$153.96 |
$204,305 |
D/D |
(1,327) |
39,257 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Global Head of R&D and Ch |
• – – |
2022-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
11,374 |
40,584 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP R&D, Chief Medical Officer |
• – – |
2021-06-05 |
4 |
D |
$176.47 |
$212,823 |
D/D |
(1,206) |
29,086 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP R&D, Chief Medical Officer |
• – – |
2021-03-05 |
4 |
D |
$164.75 |
$122,080 |
D/D |
(741) |
30,145 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Development |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
8,535 |
30,886 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Development |
• – – |
2020-06-05 |
4 |
D |
$120.65 |
$113,773 |
D/D |
(943) |
22,204 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Development |
• – – |
2020-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,800 |
23,000 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Development |
• – – |
2019-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
12,200 |
12,200 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
